Malaria's Challenge: From Infants to Genomics to Vaccines
joint with Drugs Against Tropical Protozoan Parasites: Target Selection, Structural Biology, and Rational Medicinal Chemistry
Organizer(s): Stephen L. Hoffman and Carole A. LongDate: March 03 - 08, 2002
Location: Keystone Resort, Keystone, CO, USA
The malaria and human genome projects, and recent advances in epidemiology, immunology, and vaccinology provide unique opportunities for developing methods to control malaria, a disease that kills more children annually, and has influenced the human genome more than any other infectious disease. Despite a century of research, the 2 major drugs for severe malaria were introduced by ancient Chinese (artemesinin) and Amerindian (quinine) healers, and no subunit vaccine has ever been produced against a complex, multi-stage, variant parasite like P. falciparum. The goal of this meeting is for scientists to examine host-parasite interactions in model systems and in endemic areas that provide the foundation for malaria vaccine development; review recent results from clinical trials of malaria vaccines; and discuss how these data and that from the malaria and human genome projects, computational biology, quantitative epidemiology, molecular immunology; and new vaccine technologies are being used to develop vaccines to control this ancient scourge.
Discounted Abstract Deadline: November 16 2001
Discounted Registration Deadline: January 3 2002